4 Things You Need to Know About the Singulair Mental Health Lawsuits

7/7/2022

Singulair (montelukast) is a drug prescribed to patients suffering from asthma or severe allergies that can provide symptom relief and help them manage their condition. It is a very successful drug for its manufacturer, Merck & Co. Singulair received the U.S. Food & Drug Administration’s (FDA) marketing approval in 1998; by 2004, Singulair was doing $2.62 billion in sales.

But by 2009, there were concerns that Singulair may have an adverse effect on its users’ mental health. That year, the FDA updated its potential side effect warning about Singulair to include the potential for “neuropsychiatric events.” These concerns have only grown over time — in March 2020, the FDA began requiring a “black box” warning label (the FDA’s highest danger advisory) on every unit of Singulair, warning of the potential for severe mental health symptoms, including suicidal ideation and attempted suicide. In light of these mounting concerns, the FDA now advises against the use of Singulair to treat seasonal or chronic allergies, except in cases where no other medication works for that specific patient. Merck & Co. is now facing Singulair mental health lawsuits from Singulair users who allege that the medication caused them to experience adverse mental health symptoms, including suicidal ideation.

How Were the Singulair Mental Health Symptoms Discovered?

The FDA based their new warnings and recommendations on Singulair-associated neuropsychiatric incidents that were reported to the FDA’s Sentinel Initiative, as well as animal studies and reports of suicides. The FDA identified 82 cases where a suicide was linked to montelukast. Forty-five cases involved a patient older than 17, 19 involved one younger than 17, and 18 case reports did not indicate the patient’s age. A study of montelukast in mice found the drug molecule inside the brain, indicating that the drug can cross the blood-brain barrier. This would suggest that montelukast/Singulair could enter and harm the brain as well. The combination of all this information caused the FDA to update their assessment of the possible mental health risks posed by taking Singulair.

What Are the Singulair Mental Health Symptoms

A wide range of adverse mental health symptoms have reportedly been experienced by Singulair users. These include: Suicidal thoughts, potentially escalating to suicidal ideation and attempted suicide:

Insomnia
Nightmares
Anxiety
Increased aggression
Restlessness
Irritability
Memory issues
Sleepwalking
Depression
Lack of focus and reduced ability to concentrate
Body tremors

If you or a loved one has experienced any of these Singulair mental health symptoms, you may have grounds for a Singulair lawsuit against the drug manufacturer. Contact Singulair Lawyer Timothy L. Miles today.

Should I Stop Taking Singulair?

You should talk to your doctor about your options before making any changes. The FDA has expressed concerns that not all doctors and healthcare providers are currently aware of the updated understanding of Singulair’s risk profile, so make sure that your doctor knows about the March 2020 FDA update.

Am I Eligible for The Singulair Mental Health Lawsuits?

If you or a loved one took Singulair and has since experienced any of the above adverse mental health symptoms, you may be eligible for a Singulair lawsuit. If successful, you could win compensation for any financial losses incurred due to your symptoms, including medical costs, as well as damages for pain and suffering.

Call a Singulair Lawyer today about a Singulair Lawsuit

Call a Singulair Lawyer today about a Singulair Lawsuit if you suffered from Singulair mental health symptoms.If you or a loved one is suffering from adverse Singulair mental health symptoms, you may be eligible for compensation. A Singulair Lawyer is standing by ready to review your case for free, and if we take your case, you will not pay anything up front; you won’t pay at all unless we win for you. Call Singulair Lawyer Timothy L. Miles at (855) Tim-MLaw or by submitting the form here.

Timothy L. Miles, Esq.

T imothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019).

Categories